Clinical and genomic safety of treatment with Ginkgo biloba L. leaf extract (IDN 5933/Ginkgoselect®Plus) in elderly: a randomised placebo-controlled clinical trial [GiBiEx]

BACKGROUND: Numerous health benefits have been attributed to the Ginkgo biloba leaf extract (GBLE), one of the most extensively used phytopharmaceutical drugs worldwide. Recently, concerns of the safety of the extract have been raised after a report from US National Toxicology Program (NTP) claimed...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonassi, Stefano, Prinzi, Giulia, Lamonaca, Palma, Russo, Patrizia, Paximadas, Irene, Rasoni, Giuseppe, Rossi, Raffaella, Ruggi, Marzia, Malandrino, Salvatore, Sánchez-Flores, Maria, Valdiglesias, Vanessa, Benassi, Barbara, Pacchierotti, Francesca, Villani, Paola, Panatta, Martina, Cordelli, Eugenia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778811/
https://www.ncbi.nlm.nih.gov/pubmed/29357859
http://dx.doi.org/10.1186/s12906-018-2080-5

Ejemplares similares

Ejemplares similares